Ikarian Capital, LLC Crispr Therapeutics Ag Call Options Transaction History

Ikarian Capital, LLC

  • $606 Million
  • Q4 2024

Call Options

3 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q4 2023

Feb 14, 2024
BUY
$38.62 - $72.18 $149,111 - $278,686
3,861 Added 9900.0%
3,900 $244,000
Q3 2023

Nov 14, 2023
SELL
$45.39 - $59.0 $9.08 Million - $11.8 Million
-199,961 Reduced 99.98%
39 $1,000
Q2 2023

Aug 14, 2023
BUY
$43.47 - $67.77 $8.69 Million - $13.6 Million
200,000 New
200,000 $11.2 Million

Others Institutions Holding CRSP

# of Institutions
494
Shares Held
64.3M
Call Options Held
1.68M
Put Options Held
1.95M
View Full List

About CRISPR Therapeutics AG

CRSP Quotes by TradingView
  • Ticker CRSP
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 78,009,296
  • Market Cap $3.88B
  • Description
  • CRISPR Therapeutics AG, a gene editing company, focuses on developing gene-based medicines for serious diseases using its proprietary Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)/CRISPR-associated protein 9 (Cas9) platform. Its CRISPR/Cas9 is a gene editing technology that allows for precise directed changes to genomic DNA....
More about CRSP
Track This Portfolio

Track Ikarian Capital, LLC Portfolio

Follow Ikarian Capital, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ikarian Capital, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Ikarian Capital, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email